Author

Matylda Sczaniecka-Clift

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:perturbation response prediction· 2 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Stephen P. JacksoniD· 2 shared Abhilesh S DhawanjewariD· 1 shared Almudena Serrano-BeníteziD· 1 shared Amy R. Wanders· 1 shared Angelos GlynosiD· 1 shared Anne Ramsay BowdeniD· 1 shared Antony M. Hynes-Allen· 1 shared C. J. BlumiD· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Stephen P. JacksonORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GenomicsNature Structural & Molecular BiologyPeer-reviewedApr 1, 2026

MitoPerturb-Seq identifies common and gene-specific single-cell responses to mitochondrial DNA depletion and heteroplasmy

Stephen P. Burr, Kathryn Auckland, Angelos Glynos…·Jelle van den Ameele

3 citationstop 4%

𝕏 PostBluesky

Cell BiologyThe EMBO JournalPeer-reviewedMay 17, 2024

The dCMP deaminase DCTD and the E3 ligase TOPORS are central mediators of decitabine cytotoxicity

Christopher J. Carnie, Maximilian J. Götz, Chloe S. Palma-Chaundler…·Stephen P. Jackson

This study identifies DCTD and TOPORS as key factors in decitabine cytotoxicity by showing their roles in DPC formation and repair.

41 citationstop 3%

humangenetic perturbation / CRISPR

𝕏 PostBluesky

GenomicseLifePeer-reviewedMay 22, 2020

Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance

Anne Ramsay Bowden, David A. Morales-Juarez, Matylda Sczaniecka-Clift…·Stephen P. Jackson

The paper assesses how p53 status affects CRISPR-Cas9 screen performance by comparing wild-type and TP53 knockout cells, showing that optimal design can still yield reliable results.

57 citations

humanCRISPR screen

𝕏 PostBluesky